SCH-202,596

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

SCH-202,596


SCH-202,596 is a pharmacological compound that belongs to the class of PDE5 inhibitors. It was developed by Schering-Plough, a pharmaceutical company, for the potential treatment of erectile dysfunction and pulmonary arterial hypertension. However, the development of SCH-202,596 was discontinued and it never reached the market.

History[edit | edit source]

SCH-202,596 was first synthesized by Schering-Plough in the late 1990s as part of their research into PDE5 inhibitors. The compound showed promising results in preclinical trials, demonstrating the ability to inhibit the phosphodiesterase type 5 enzyme, which is involved in the regulation of blood flow in the penis and lungs.

Pharmacology[edit | edit source]

SCH-202,596 is a selective inhibitor of the phosphodiesterase type 5 enzyme. This enzyme is responsible for the breakdown of cyclic guanosine monophosphate (cGMP), a molecule that plays a crucial role in the relaxation of smooth muscle tissue. By inhibiting PDE5, SCH-202,596 increases the levels of cGMP, leading to the relaxation of smooth muscle tissue in the penis and lungs, and thus improving blood flow.

Clinical Trials[edit | edit source]

Despite the promising preclinical results, the development of SCH-202,596 was discontinued before it reached clinical trials. The reasons for this are not publicly disclosed, but it is speculated that the decision was influenced by the competitive landscape of the PDE5 inhibitor market, dominated by drugs such as sildenafil (Viagra) and tadalafil (Cialis).

See Also[edit | edit source]

FlattenedRoundPills.jpg
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP1 injections from $125 and up biweekly

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.

Why choose W8MD?

Book Your Appointment

Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia and visit Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD